New York has rejected a request from Louisiana to extradite a doctor who was charged with prescribing abortion pills to a ...

SOUTH BEND, Ind. (WNDU) - The University of Notre Dame is making headlines again — not in athletics, but in Forbes’ list of ...

Telehealth stock Hims & Hers ( HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy.

PM Modi is visiting the US at a critical moment. Trump has called India “a big abuser on trade” but America’s ...

The U.S. Senate has confirmed most of President Donald Trump's picks for his cabinet so far. Here are Trump's choices for some key posts. PETE HEGSETH, ...

Capital, an investment firm led by Donald Trump Jr., Omeed Malik and Chris Buskirk, is investing in Enhanced Ltd., a startup ...

With 90% of the U.S. population living within 10 miles of a Walmart store, recalls of products they sell can have widespread ...

The shocking reality of 'unacceptable' A&E waits and being stuck on long NHS waiting lists for treatment is said to have left ...

Texas, says the National Science Foundation has given money to thousands of "Woke DEI" studies. Researchers say that's ...

Target now has six product recalls active, after the Food and Drug Administration ( FDA) issued them for the same products.

Achieving Universal Health Coverage (UHC) in Bangladesh remains a challenge due to the high out-of-pocket healthcare costs, particularly for medicines.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.